Kyverna Therapeutics (Kyverna Therapeutics) Other Long Term Assets : $1.74 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Kyverna Therapeutics Other Long Term Assets?

Kyverna Therapeutics's other long-term assets for the quarter that ended in Mar. 2024 was $1.74 Mil.

Kyverna Therapeutics's quarterly other long-term assets increased from Sep. 2023 ($2.01 Mil) to Dec. 2023 ($3.92 Mil) but then stayed the same from Dec. 2023 ($3.92 Mil) to Mar. 2024 ($1.74 Mil).

Kyverna Therapeutics's annual other long-term assets increased from Dec. 2021 ($0.59 Mil) to Dec. 2022 ($1.23 Mil) and increased from Dec. 2022 ($1.23 Mil) to Dec. 2023 ($3.92 Mil).

Kyverna Therapeutics Other Long Term Assets Historical Data

The historical data trend for Kyverna Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyverna Therapeutics Other Long Term Assets Chart

Kyverna Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Other Long Term Assets

0.59

1.23

3.92

Kyverna Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial			1.23	-	2.01	3.92	1.74

Kyverna Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Kyverna Therapeutics (Kyverna Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kyverna Therapeutics Inc (NAS:KYTX) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

5980 Horton Street, STE 550, Emeryville, CA, USA, 94608

Website

https://www.kyvernatx.com

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR.

Kyverna Therapeutics (Kyverna Therapeutics) Headlines

From GuruFocus

Kyverna Therapeutics Announces Pricing of Upsized Initial Public Offering

By PRNewswire • 02-12-2024